drug protocol number

A5481150

drug sponsor

pfizer

drug study

PALBOCICLIB

drug trial site

King Fahad Specialist Hospital (Dammam) , King Abdulaziz Medical City NG (Riyadh) , King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase